Concepts (362)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 74 | 2025 | 585 | 15.030 |
Why?
|
| Arthroplasty, Replacement, Hip | 48 | 2023 | 749 | 10.030 |
Why?
|
| Knee Prosthesis | 28 | 2023 | 208 | 8.460 |
Why?
|
| Knee Joint | 43 | 2025 | 688 | 6.340 |
Why?
|
| Hip Prosthesis | 26 | 2023 | 508 | 6.130 |
Why?
|
| Femur | 20 | 2020 | 349 | 4.560 |
Why?
|
| Surgery, Computer-Assisted | 16 | 2017 | 49 | 4.420 |
Why?
|
| Prosthesis Failure | 24 | 2023 | 478 | 3.540 |
Why?
|
| Osteoarthritis, Knee | 21 | 2025 | 334 | 3.340 |
Why?
|
| Prosthesis Design | 28 | 2023 | 448 | 3.210 |
Why?
|
| Middle Aged | 81 | 2025 | 7555 | 2.970 |
Why?
|
| Tibia | 17 | 2019 | 231 | 2.970 |
Why?
|
| Retrospective Studies | 55 | 2022 | 3062 | 2.650 |
Why?
|
| Hip Joint | 17 | 2017 | 519 | 2.620 |
Why?
|
| Aged | 71 | 2025 | 7669 | 2.600 |
Why?
|
| Humans | 124 | 2025 | 22848 | 2.580 |
Why?
|
| Reoperation | 25 | 2023 | 846 | 2.530 |
Why?
|
| Bone Cements | 7 | 2023 | 82 | 2.490 |
Why?
|
| Female | 83 | 2025 | 12677 | 2.330 |
Why?
|
| Male | 82 | 2025 | 12453 | 2.300 |
Why?
|
| Postoperative Period | 22 | 2020 | 317 | 2.140 |
Why?
|
| Pain, Postoperative | 11 | 2020 | 294 | 1.930 |
Why?
|
| Postoperative Complications | 15 | 2022 | 819 | 1.900 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2017 | 588 | 1.730 |
Why?
|
| Osteoarthritis, Hip | 5 | 2018 | 95 | 1.700 |
Why?
|
| Patient Satisfaction | 8 | 2019 | 295 | 1.690 |
Why?
|
| Metal-on-Metal Joint Prostheses | 5 | 2017 | 49 | 1.630 |
Why?
|
| Prospective Studies | 21 | 2020 | 1528 | 1.610 |
Why?
|
| Treatment Outcome | 31 | 2023 | 2960 | 1.570 |
Why?
|
| Adult | 38 | 2019 | 6584 | 1.550 |
Why?
|
| Acetabulum | 6 | 2016 | 215 | 1.490 |
Why?
|
| Bone Malalignment | 7 | 2014 | 19 | 1.470 |
Why?
|
| Anticoagulants | 4 | 2015 | 76 | 1.440 |
Why?
|
| Venous Thromboembolism | 3 | 2015 | 34 | 1.380 |
Why?
|
| Joint Diseases | 4 | 2016 | 105 | 1.340 |
Why?
|
| Radiography | 20 | 2017 | 549 | 1.300 |
Why?
|
| Range of Motion, Articular | 15 | 2017 | 643 | 1.290 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2017 | 947 | 1.270 |
Why?
|
| Recovery of Function | 11 | 2016 | 260 | 1.190 |
Why?
|
| Noise | 3 | 2017 | 23 | 1.170 |
Why?
|
| Warfarin | 4 | 2015 | 23 | 1.160 |
Why?
|
| Bone Density | 3 | 2018 | 137 | 1.120 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2016 | 182 | 1.100 |
Why?
|
| Chromium | 3 | 2016 | 82 | 1.070 |
Why?
|
| Cobalt | 3 | 2016 | 105 | 1.050 |
Why?
|
| Metals | 4 | 2017 | 132 | 1.040 |
Why?
|
| Aspirin | 3 | 2015 | 70 | 1.030 |
Why?
|
| Prosthesis-Related Infections | 5 | 2020 | 182 | 1.030 |
Why?
|
| Foreign-Body Reaction | 2 | 2017 | 25 | 0.990 |
Why?
|
| Venous Thrombosis | 2 | 2015 | 44 | 0.900 |
Why?
|
| Osteolysis | 2 | 2017 | 135 | 0.880 |
Why?
|
| Aged, 80 and over | 18 | 2019 | 4055 | 0.860 |
Why?
|
| Titanium | 4 | 2020 | 159 | 0.850 |
Why?
|
| Arthritis | 4 | 2020 | 43 | 0.830 |
Why?
|
| Biomechanical Phenomena | 11 | 2017 | 582 | 0.810 |
Why?
|
| Synovial Fluid | 2 | 2020 | 87 | 0.790 |
Why?
|
| Cholecalciferol | 1 | 2022 | 6 | 0.790 |
Why?
|
| Hip Dislocation | 6 | 2023 | 72 | 0.780 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2021 | 4 | 0.770 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 977 | 0.760 |
Why?
|
| Age Factors | 9 | 2018 | 657 | 0.760 |
Why?
|
| Arthroplasty, Replacement | 4 | 2013 | 142 | 0.760 |
Why?
|
| Accelerometry | 2 | 2012 | 69 | 0.740 |
Why?
|
| Surgical Wound | 2 | 2018 | 9 | 0.730 |
Why?
|
| Surgical Wound Infection | 3 | 2021 | 85 | 0.710 |
Why?
|
| Registries | 2 | 2018 | 166 | 0.690 |
Why?
|
| Pain Measurement | 4 | 2016 | 446 | 0.670 |
Why?
|
| Specimen Handling | 1 | 2020 | 40 | 0.660 |
Why?
|
| Lower Extremity | 3 | 2015 | 29 | 0.660 |
Why?
|
| Periprosthetic Fractures | 1 | 2020 | 23 | 0.650 |
Why?
|
| Incidence | 9 | 2018 | 649 | 0.630 |
Why?
|
| Computer-Aided Design | 2 | 2016 | 10 | 0.620 |
Why?
|
| Joint Dislocations | 3 | 2023 | 53 | 0.620 |
Why?
|
| Equipment Failure Analysis | 4 | 2014 | 90 | 0.620 |
Why?
|
| Research Design | 3 | 2015 | 147 | 0.590 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 685 | 0.590 |
Why?
|
| Intermittent Pneumatic Compression Devices | 2 | 2015 | 6 | 0.580 |
Why?
|
| Risk Factors | 9 | 2022 | 1942 | 0.580 |
Why?
|
| Acceleration | 3 | 2012 | 19 | 0.580 |
Why?
|
| Risk Assessment | 3 | 2018 | 485 | 0.560 |
Why?
|
| Ankle Joint | 5 | 2016 | 37 | 0.560 |
Why?
|
| Weight-Bearing | 2 | 2014 | 133 | 0.550 |
Why?
|
| Genu Varum | 1 | 2017 | 4 | 0.540 |
Why?
|
| Cadaver | 4 | 2012 | 344 | 0.540 |
Why?
|
| Pelvic Bones | 1 | 2016 | 16 | 0.520 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2019 | 490 | 0.520 |
Why?
|
| Young Adult | 10 | 2019 | 1721 | 0.510 |
Why?
|
| Femur Neck | 1 | 2016 | 21 | 0.510 |
Why?
|
| Prosthesis Fitting | 2 | 2013 | 19 | 0.510 |
Why?
|
| Supine Position | 1 | 2016 | 14 | 0.500 |
Why?
|
| Patient Discharge | 3 | 2019 | 124 | 0.500 |
Why?
|
| Analgesics, Opioid | 6 | 2020 | 210 | 0.500 |
Why?
|
| Posture | 4 | 2017 | 54 | 0.500 |
Why?
|
| Hypersensitivity | 1 | 2016 | 34 | 0.490 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 282 | 0.460 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 16 | 0.460 |
Why?
|
| Joint Instability | 5 | 2025 | 363 | 0.450 |
Why?
|
| Osteoarthritis | 2 | 2016 | 308 | 0.440 |
Why?
|
| Reproducibility of Results | 6 | 2019 | 558 | 0.440 |
Why?
|
| Patella | 1 | 2014 | 63 | 0.430 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 68 | 0.420 |
Why?
|
| Leg Length Inequality | 1 | 2013 | 9 | 0.410 |
Why?
|
| Time Factors | 8 | 2019 | 1220 | 0.410 |
Why?
|
| Fibrosis | 1 | 2013 | 29 | 0.410 |
Why?
|
| Computer Simulation | 2 | 2016 | 160 | 0.400 |
Why?
|
| Patellofemoral Joint | 1 | 2014 | 65 | 0.400 |
Why?
|
| Missouri | 4 | 2016 | 22 | 0.400 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 11 | 0.390 |
Why?
|
| United States | 9 | 2018 | 1726 | 0.390 |
Why?
|
| Gait | 3 | 2025 | 363 | 0.390 |
Why?
|
| Muscular Diseases | 1 | 2012 | 12 | 0.380 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 361 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 4 | 2018 | 368 | 0.370 |
Why?
|
| Blood Transfusion | 4 | 2022 | 61 | 0.360 |
Why?
|
| Viscosity | 4 | 2019 | 10 | 0.350 |
Why?
|
| Pain | 4 | 2019 | 370 | 0.350 |
Why?
|
| Porosity | 2 | 2022 | 57 | 0.350 |
Why?
|
| Rotation | 4 | 2014 | 125 | 0.350 |
Why?
|
| Adolescent | 6 | 2019 | 1775 | 0.350 |
Why?
|
| Osteoporosis | 1 | 2011 | 69 | 0.340 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 1494 | 0.330 |
Why?
|
| Spinal Fusion | 1 | 2016 | 435 | 0.330 |
Why?
|
| Cartilage, Articular | 1 | 2014 | 389 | 0.330 |
Why?
|
| Joint Prosthesis | 4 | 2019 | 77 | 0.320 |
Why?
|
| Patient Positioning | 4 | 2017 | 35 | 0.320 |
Why?
|
| Rotator Cuff | 1 | 2012 | 291 | 0.310 |
Why?
|
| Length of Stay | 5 | 2019 | 279 | 0.300 |
Why?
|
| Body Mass Index | 4 | 2020 | 400 | 0.300 |
Why?
|
| Femur Head | 4 | 2023 | 63 | 0.290 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2019 | 232 | 0.290 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2018 | 11 | 0.280 |
Why?
|
| Chi-Square Distribution | 3 | 2016 | 110 | 0.280 |
Why?
|
| Corrosion | 3 | 2017 | 118 | 0.270 |
Why?
|
| Absorptiometry, Photon | 2 | 2018 | 70 | 0.270 |
Why?
|
| Arthroplasty, Replacement, Elbow | 2 | 2019 | 7 | 0.270 |
Why?
|
| Osteocytes | 2 | 2019 | 15 | 0.270 |
Why?
|
| Polyethylene | 4 | 2019 | 114 | 0.260 |
Why?
|
| Blood Loss, Surgical | 2 | 2020 | 53 | 0.260 |
Why?
|
| Hip Fractures | 2 | 2018 | 25 | 0.260 |
Why?
|
| Arthroscopy | 2 | 2014 | 1042 | 0.260 |
Why?
|
| Sex Factors | 3 | 2017 | 381 | 0.260 |
Why?
|
| Pain Management | 4 | 2020 | 125 | 0.250 |
Why?
|
| Patient Readmission | 3 | 2018 | 116 | 0.250 |
Why?
|
| Cytokines | 2 | 2019 | 167 | 0.250 |
Why?
|
| Elbow Joint | 2 | 2019 | 113 | 0.240 |
Why?
|
| Hemorrhage | 2 | 2015 | 73 | 0.240 |
Why?
|
| Hand | 2 | 2018 | 33 | 0.240 |
Why?
|
| Awards and Prizes | 2 | 2016 | 19 | 0.230 |
Why?
|
| Machine Learning | 1 | 2025 | 73 | 0.220 |
Why?
|
| Cohort Studies | 4 | 2020 | 1621 | 0.220 |
Why?
|
| Comorbidity | 2 | 2022 | 354 | 0.220 |
Why?
|
| Stress, Mechanical | 3 | 2014 | 150 | 0.220 |
Why?
|
| Double-Blind Method | 2 | 2022 | 295 | 0.210 |
Why?
|
| Therapeutic Irrigation | 2 | 2020 | 50 | 0.210 |
Why?
|
| Patient Selection | 2 | 2014 | 157 | 0.210 |
Why?
|
| Urinary Retention | 1 | 2022 | 11 | 0.200 |
Why?
|
| Time and Motion Studies | 1 | 2022 | 15 | 0.200 |
Why?
|
| Algorithms | 3 | 2019 | 305 | 0.200 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 30 | 0.200 |
Why?
|
| Opioid-Related Disorders | 2 | 2020 | 39 | 0.200 |
Why?
|
| Dietary Supplements | 1 | 2022 | 54 | 0.190 |
Why?
|
| Vitamin D | 1 | 2022 | 33 | 0.190 |
Why?
|
| Equipment Design | 2 | 2012 | 104 | 0.190 |
Why?
|
| Postural Balance | 1 | 2022 | 97 | 0.180 |
Why?
|
| Cementation | 1 | 2021 | 30 | 0.180 |
Why?
|
| Orthopedics | 2 | 2013 | 104 | 0.180 |
Why?
|
| Surface Properties | 2 | 2019 | 128 | 0.170 |
Why?
|
| Refuse Disposal | 1 | 2020 | 2 | 0.170 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 17 | 0.170 |
Why?
|
| Tranexamic Acid | 1 | 2020 | 17 | 0.170 |
Why?
|
| Leukocyte Count | 1 | 2020 | 53 | 0.170 |
Why?
|
| Prescriptions | 1 | 2020 | 13 | 0.170 |
Why?
|
| Acetaminophen | 1 | 2020 | 19 | 0.170 |
Why?
|
| Los Angeles | 2 | 2017 | 10 | 0.160 |
Why?
|
| Arthroplasty | 2 | 2018 | 146 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 62 | 0.160 |
Why?
|
| Neutrophils | 1 | 2020 | 85 | 0.160 |
Why?
|
| Osteoclasts | 1 | 2019 | 22 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 125 | 0.160 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 108 | 0.160 |
Why?
|
| Pain Perception | 1 | 2019 | 5 | 0.160 |
Why?
|
| Cell Differentiation | 1 | 2019 | 111 | 0.160 |
Why?
|
| Wound Healing | 2 | 2018 | 140 | 0.160 |
Why?
|
| Pelvis | 2 | 2016 | 25 | 0.160 |
Why?
|
| Oxycodone | 1 | 2019 | 4 | 0.150 |
Why?
|
| Apoptosis | 1 | 2019 | 172 | 0.150 |
Why?
|
| Survivorship | 1 | 2019 | 20 | 0.150 |
Why?
|
| Mobile Applications | 1 | 2019 | 23 | 0.150 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 17 | 0.150 |
Why?
|
| Logistic Models | 2 | 2016 | 320 | 0.150 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 62 | 0.150 |
Why?
|
| alpha-Defensins | 1 | 2018 | 3 | 0.150 |
Why?
|
| Ceramics | 2 | 2015 | 18 | 0.150 |
Why?
|
| Morphine | 1 | 2019 | 71 | 0.150 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 7 | 0.150 |
Why?
|
| Surgeons | 2 | 2019 | 80 | 0.150 |
Why?
|
| Databases, Factual | 2 | 2018 | 300 | 0.140 |
Why?
|
| Bone Remodeling | 1 | 2018 | 47 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 93 | 0.140 |
Why?
|
| Drainage | 1 | 2018 | 38 | 0.140 |
Why?
|
| Arthritis, Infectious | 1 | 2018 | 49 | 0.140 |
Why?
|
| Preoperative Period | 2 | 2020 | 79 | 0.140 |
Why?
|
| Knee | 1 | 2017 | 42 | 0.140 |
Why?
|
| Spine | 1 | 2018 | 98 | 0.140 |
Why?
|
| Motion | 1 | 2016 | 20 | 0.130 |
Why?
|
| Ions | 1 | 2016 | 40 | 0.130 |
Why?
|
| Sacrum | 1 | 2016 | 17 | 0.130 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.130 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 31 | 0.130 |
Why?
|
| Fascia Lata | 1 | 2016 | 14 | 0.130 |
Why?
|
| Thigh | 1 | 2016 | 26 | 0.130 |
Why?
|
| Rats | 2 | 2019 | 554 | 0.130 |
Why?
|
| Auditory Perception | 1 | 2016 | 26 | 0.130 |
Why?
|
| Chlorhexidine | 1 | 2016 | 63 | 0.130 |
Why?
|
| Midwestern United States | 1 | 2016 | 36 | 0.130 |
Why?
|
| Stockings, Compression | 1 | 2015 | 1 | 0.130 |
Why?
|
| Internal Fixators | 1 | 2016 | 32 | 0.120 |
Why?
|
| Preoperative Care | 2 | 2014 | 102 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 274 | 0.120 |
Why?
|
| Tennessee | 1 | 2015 | 6 | 0.120 |
Why?
|
| Great Lakes Region | 1 | 2015 | 1 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 477 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 20 | 0.120 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 54 | 0.120 |
Why?
|
| Joint Capsule | 2 | 2012 | 52 | 0.120 |
Why?
|
| Alloys | 1 | 2015 | 90 | 0.120 |
Why?
|
| Regional Health Planning | 1 | 2014 | 4 | 0.120 |
Why?
|
| Chemoprevention | 1 | 2014 | 4 | 0.120 |
Why?
|
| Patients | 1 | 2015 | 31 | 0.110 |
Why?
|
| Drug Monitoring | 1 | 2014 | 10 | 0.110 |
Why?
|
| Software | 1 | 2014 | 57 | 0.110 |
Why?
|
| Survival Rate | 1 | 2015 | 270 | 0.110 |
Why?
|
| Obesity | 1 | 2017 | 263 | 0.110 |
Why?
|
| Perception | 1 | 2015 | 63 | 0.110 |
Why?
|
| Knee Dislocation | 1 | 2014 | 3 | 0.110 |
Why?
|
| Arthritis, Juvenile | 1 | 2014 | 7 | 0.110 |
Why?
|
| Shoulder Joint | 2 | 2012 | 642 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2016 | 223 | 0.110 |
Why?
|
| Femoral Nerve | 1 | 2014 | 8 | 0.110 |
Why?
|
| Sexual Behavior | 1 | 2014 | 43 | 0.110 |
Why?
|
| Amides | 1 | 2014 | 15 | 0.110 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2014 | 6 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 146 | 0.110 |
Why?
|
| Analgesia, Epidural | 1 | 2014 | 51 | 0.110 |
Why?
|
| Patellar Ligament | 1 | 2014 | 36 | 0.110 |
Why?
|
| Fluoroscopy | 1 | 2013 | 36 | 0.110 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 78 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 305 | 0.100 |
Why?
|
| Connective Tissue | 1 | 2013 | 20 | 0.100 |
Why?
|
| Nerve Block | 1 | 2014 | 61 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2014 | 500 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 377 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2025 | 45 | 0.100 |
Why?
|
| Pressure | 1 | 2013 | 54 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2013 | 101 | 0.100 |
Why?
|
| Quality of Life | 1 | 2017 | 504 | 0.100 |
Why?
|
| Leg | 1 | 2013 | 43 | 0.100 |
Why?
|
| Pregnancy | 1 | 2013 | 303 | 0.100 |
Why?
|
| Femoral Neck Fractures | 1 | 2012 | 10 | 0.100 |
Why?
|
| Foreign-Body Migration | 1 | 2012 | 12 | 0.100 |
Why?
|
| Vasculitis | 1 | 2012 | 24 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2014 | 205 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 283 | 0.100 |
Why?
|
| Hip | 1 | 2013 | 64 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2012 | 82 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2012 | 42 | 0.100 |
Why?
|
| Chromium Alloys | 1 | 2012 | 42 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2012 | 83 | 0.100 |
Why?
|
| Hemiarthroplasty | 1 | 2012 | 35 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 208 | 0.090 |
Why?
|
| Arthritis, Psoriatic | 1 | 2012 | 14 | 0.090 |
Why?
|
| Patellar Dislocation | 1 | 2012 | 21 | 0.090 |
Why?
|
| Computers, Handheld | 1 | 2011 | 11 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2011 | 21 | 0.090 |
Why?
|
| External Fixators | 1 | 2011 | 8 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 26 | 0.090 |
Why?
|
| Health Status | 1 | 2012 | 173 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2013 | 354 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2011 | 49 | 0.090 |
Why?
|
| Movement | 1 | 2011 | 95 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 713 | 0.090 |
Why?
|
| Shoulder Injuries | 1 | 2012 | 140 | 0.090 |
Why?
|
| Animals | 2 | 2019 | 3025 | 0.090 |
Why?
|
| Arthralgia | 1 | 2012 | 119 | 0.090 |
Why?
|
| Athletic Injuries | 1 | 2012 | 148 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 311 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 3 | 2016 | 104 | 0.080 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 38 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2011 | 189 | 0.070 |
Why?
|
| Rotator Cuff Injuries | 1 | 2012 | 310 | 0.070 |
Why?
|
| Risk | 2 | 2019 | 178 | 0.070 |
Why?
|
| Elective Surgical Procedures | 2 | 2019 | 34 | 0.070 |
Why?
|
| Early Ambulation | 2 | 2019 | 15 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2019 | 241 | 0.060 |
Why?
|
| Medicare | 2 | 2015 | 108 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 401 | 0.050 |
Why?
|
| Urinary Catheters | 1 | 2022 | 5 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2022 | 8 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 16 | 0.050 |
Why?
|
| Bandages | 1 | 2021 | 5 | 0.040 |
Why?
|
| Silver | 1 | 2021 | 5 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 119 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 16 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 85 | 0.040 |
Why?
|
| Bone-Implant Interface | 1 | 2019 | 7 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 59 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 91 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 73 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2019 | 77 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2019 | 254 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 305 | 0.040 |
Why?
|
| Demography | 1 | 2019 | 65 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 116 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 210 | 0.040 |
Why?
|
| Analgesics | 1 | 2019 | 70 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 110 | 0.040 |
Why?
|
| Colitis | 1 | 2017 | 28 | 0.030 |
Why?
|
| Smoking | 1 | 2018 | 163 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 25 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 116 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 71 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 539 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 52 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 453 | 0.030 |
Why?
|
| Robotic Surgical Procedures | 1 | 2016 | 26 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2015 | 17 | 0.030 |
Why?
|
| Medicaid | 1 | 2015 | 26 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 31 | 0.030 |
Why?
|
| Spain | 1 | 2014 | 7 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2014 | 21 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 5 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 18 | 0.030 |
Why?
|
| Zirconium | 1 | 2014 | 4 | 0.030 |
Why?
|
| Aluminum Oxide | 1 | 2014 | 6 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 109 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2016 | 162 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 83 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2014 | 7 | 0.030 |
Why?
|
| Hospitals | 1 | 2015 | 152 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 71 | 0.030 |
Why?
|
| New York City | 1 | 2014 | 11 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2015 | 61 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 349 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 249 | 0.030 |
Why?
|
| Device Removal | 1 | 2014 | 76 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 88 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 205 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 139 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2014 | 99 | 0.030 |
Why?
|
| Fingers | 1 | 2012 | 8 | 0.020 |
Why?
|
| Dermatologic Agents | 1 | 2012 | 6 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 70 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 262 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 146 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 150 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2012 | 79 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 273 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 70 | 0.020 |
Why?
|
| Polyethylenes | 1 | 2009 | 38 | 0.020 |
Why?
|
| Child | 1 | 2012 | 990 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 118 | 0.020 |
Why?
|